NanoVibronix jumps 93% on FDA nod for ultrasound pain therapy device

Healthcare equipment maker NanoVibronix, Inc. (NASDAQ:NAOV) added ~93% on Monday after the company announced that the FDA issued 510(k) clearance for its ultrasound pain therapy device PainShield MD PLUS.
PainShield MD PLUS, a non-pharmaceutical treatment option for chronic pain, is an advancement of its predecessor original PainShield M.D., with features to double the treatment area.
“Securing 510(k) clearance for PainShield Plus is a key milestone towards achieving permanent clearance from the FDA and full-scale commercial marketability,” Chief Executive Brian Murphy remarked.
The company plans to submit a 510(k) application for its over-the-counter product, PainShield Relief, in the near term.
In May, NanoVibronix (NAOV) shares climbed after the company announced the submission of the 510(k) application to the FDA for PainShield MD PLUS.